Back to top
more

Invitae Corporation (NVTA)

(Delayed Data from NYSE)

$24.76 USD

24.76
946,453

+0.60 (2.48%)

Updated May 3, 2019 04:02 PM ET

After-Market: $24.77 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Invitae (NVTA) Dips More Than Broader Markets: What You Should Know

Invitae (NVTA) closed at $36.66 in the latest trading session, marking a -1.5% move from the prior day.

Moving Average Crossover Alert: Invitae Corp (NVTA)

Invitae Corporation (NVTA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Invitae (NVTA) Stock Moves -0.39%: What You Should Know

Invitae (NVTA) closed at $35.96 in the latest trading session, marking a -0.39% move from the prior day.

Invitae (NVTA) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Invitae (NVTA) closed at $39.07, marking a -0.79% move from the previous day.

Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know

Invitae (NVTA) closed the most recent trading day at $34.45, moving -0.61% from the previous trading session.

Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know

Invitae (NVTA) closed the most recent trading day at $38.66, moving -0.46% from the previous trading session.

Invitae (NVTA) Reports Q4 Loss, Tops Revenue Estimates

Invitae (NVTA) delivered earnings and revenue surprises of -8.62% and 2.62%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Invitae (NVTA) to Report Q4 Earnings: What's in the Offing?

Invitae's (NVTA) fourth-quarter results are likely to reflect strength in genetic testing.

Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know

Invitae (NVTA) closed the most recent trading day at $51.09, moving -1.64% from the previous trading session.

Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Invitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Invitae (NVTA) closed at $49.70, marking a -0.98% move from the previous day.

Invitae (NVTA) Stock Moves -0.96%: What You Should Know

Invitae (NVTA) closed the most recent trading day at $47.69, moving -0.96% from the previous trading session.

Kevin Cook headshot

Bear of the Day: Illumina (ILMN)

Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs

Kevin Cook headshot

Cathie Put the Wood to Wall Street: TSLA, SQ, ROKU, CRSP, BIDU

Her focus on disruptive innovation broke the mold of Wall Street money management.

Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates

Invitae (NVTA) delivered earnings and revenue surprises of -3.33% and 14.63%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Invitae (NVTA) to Report Q3 Earnings: What's in the Cards?

Invitae's (NVTA) genetic testing business is expected to have gained from expansion of biopharma partnerships in Q3.

Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Invitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Neena Mishra headshot

Why You Should Invest in Genomics ETFs

Genomics ETFs have surged of late; here's why

Daniel Laboe headshot

The Innovative Future Of ETFs

Ark Invest is driving a new generation of actively managed ETFs

Are Options Traders Betting on a Big Move in Invitae (NVTA) Stock?

Investors need to pay close attention to Invitae (NVTA) stock based on the movements in the options market lately.

Kevin Cook headshot

7 Diagnostic and Genomic Stocks Storming Into October

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates

Invitae (NVTA) delivered earnings and revenue surprises of -24.19% and 13.23%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Invitae (NVTA) Stock Sinks As Market Gains: What You Should Know

Invitae (NVTA) closed the most recent trading day at $29.12, moving -1.59% from the previous trading session.

Analysts Estimate Invitae (NVTA) to Report a Decline in Earnings: What to Look Out for

Invitae (NVTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Invitae (NVTA) to Report Q2 Earnings: What's in the Cards?

Genetic testing is likely to drive Invitae's (NVTA) Q2 earnings.